目的探讨康复期锻炼对乳腺癌患者生命质量的影响。方法采用横断面研究方法,整群抽样上海癌症康复俱乐部1 956名女性乳腺癌康复期患者进行问卷调查,调查问卷采用欧洲癌症研究与治疗组织生命质量量表(quality of life questionnaire-core ...目的探讨康复期锻炼对乳腺癌患者生命质量的影响。方法采用横断面研究方法,整群抽样上海癌症康复俱乐部1 956名女性乳腺癌康复期患者进行问卷调查,调查问卷采用欧洲癌症研究与治疗组织生命质量量表(quality of life questionnaire-core 30,EORTC QLQ-C30)和乳腺癌生存质量量表(quality of life questionnaire-breast cancer module 23,QLQ-BR23)。结果 QLQ-BR23的信度和效度分别为0.898和0.904,EORTC QLQ-C30的信度和效度分别为0.988和0.989;对于QLQ-BR23量表,康复锻炼、锻炼次数和生命质量均无统计学意义。但是参与康复锻炼和锻炼次数≥5次/周患者的功能症状总得分高于未参加康复锻炼和康复锻炼<5次/周患者。对于EORTC QLQ-C30量表,通过调整社会人口学等因素,参加康复锻炼患者的躯体功能及总体健康状况得分均显著高于不参加体育锻炼患者(P<0.05,PAdjusted<0.05);康复锻炼≥5次/周患者的5个功能维度及总体健康状况得分均高于康复锻炼<5次/周患者,但只有躯体功能差异有统计学意义(P<0.05,PAdjusted<0.05)。结论参加康复锻炼的乳腺癌患者总体生命质量高于未参加锻炼者,康复锻炼对提高乳腺癌患者的生命质量有积极影响。展开更多
Objective To explore quality of life(QOL) and its influencing factors in patients with lung cancer.Methods A QOL questionnaire(European Organization for Research and Treatment of Cancer [EORTC] Quality of Life Questio...Objective To explore quality of life(QOL) and its influencing factors in patients with lung cancer.Methods A QOL questionnaire(European Organization for Research and Treatment of Cancer [EORTC] Quality of Life Questionnaire-Core 30 [QLQ-C30] Chinese version) was used with 138 patients with lung cancer participating in the study. A statistical description of the general characteristics of the patients with lung cancer was performed. The patients' QLQ-C30 scores were compared with the reference value for each dimension. To analyze the influence of QOL in different genders, age groups, and cancer stages, ttests and rank sum tests were used to compare the differences in QOL using a 5% significance level. Results The QLQ-C30 function scores in PF(physical functioning), EF(emotional functioning), SF(social functioning), and GH(global functioning), and symptom scales in NV(nausea and vomiting), DY(dyspnea), SL(insomnia), and FI(financial difficulties) were significantly different(P < 0.05) in comparison to the reference values. Female patients were worse than males(P < 0.05) in EF, NV, and DI(diarrhea). The later the stage of lung cancer, the worse the quality of life became; the functional scales in RF(role functioning), EF, CF, SF, and GH, and symptom scales in PA(pain), AP(appetite), and SL differences were statistically significant(P < 0.05). Conclusion This study aids understanding of the status of the quality of life of Chinese patients with cancer and might be useful for clinical work, theory research, and health policymakers.展开更多
Objective The primary aim of the study was to compare two nutritional status evaluation tools： the Patient-Generated Subjective Global Assessment（PG-SGA） and Nutritional Risk Screening（NRS-2002）. Using the Europe...Objective The primary aim of the study was to compare two nutritional status evaluation tools： the Patient-Generated Subjective Global Assessment（PG-SGA） and Nutritional Risk Screening（NRS-2002）. Using the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30（EORTC QLQ-C30）, the second aim was to provide constructive advice regarding the quality of life of patients with malignancy. Methods This study enrolled 312 oncology patients and assessed their nutritional status and quality of life using the PG-SGA, NRS-2002, and EORTC QLQ-C30. Results The data indicate that 6% of the cancer patients were well nourished. The SGA-A had a higher sensitivity（93.73%） but a poorer specificity（2.30%） than the NRS-2002（69.30% and 25.00%, respectively） after comparison with albumin. There was a low negative correlation and a high similarity between the PG-SGA and NRS-2002 for evaluating nutritional status, and there was a significant difference in the median PG-SGA scores for each of the SGA classifications（P 〈 0.001）. The SGA-C group showed the highest PG-SGA scores and lowest body mass index. The majority of the target population received 2 points for each item in our 11-item questionnaire from the EORTC QLQ-C30. Conclusion The data indicate that the PG-SGA is more useful and suitable for evaluating nutritional status than the NRS-2002. Additionally, early nutrition monitoring can prevent malnutrition and improve the quality of life of cancer patients.展开更多
目的:观察在非小细胞肺癌病人中,与常规化疗模式相比,时辰化疗在疗效、毒副反应和生活质量上是否具有优越性。方法:自2004年4月至2006年2月将NP方案以时辰给药方式治疗23例非小细胞肺癌患者为时辰组,给药方法如下:NVB12.5mg/m2/d,自15:0...目的:观察在非小细胞肺癌病人中,与常规化疗模式相比,时辰化疗在疗效、毒副反应和生活质量上是否具有优越性。方法:自2004年4月至2006年2月将NP方案以时辰给药方式治疗23例非小细胞肺癌患者为时辰组,给药方法如下:NVB12.5mg/m2/d,自15:00至03:00,峰值在21:00,d1-d4;PDD20mg/m2/d,自10:00至22:00,峰值在16:00,d1-d4;同期常规化疗21例作为对照组,对照组常规外周静脉输液,NVB25mg/m2,d1,d8;PDD25mg/m2,d3-d5;两组均为21天为1周期,每个病人至少接受2个周期化疗。采用欧洲生命质量协作组癌症核心量表(quality of life questionnaire:core30,EORTCQLQ-C30)第三版和肺癌补充问卷QLQ-LC13对患者进行自我问卷调查,所有患者于化疗前1天,2周期化疗结束后1周进行2次评估。两个量表各项原始得分经线性公式转换成0-100,功能量表和整体生活质量量表得分越高提示生活质量越好,而症状量表及单项条目得分越高提示症状越明显,生活质量越差。结果:与对照组相比,时辰组病人的中位TTP提高了1.3个月(6.2月:4.9月,P<0.05),一年生存率提高了13.25%(60.87%vs47.62%,P<0.05),而中位生存期时辰组为13.8月,对照组为11.9月,时辰组有提高的趋势,但无统计学差异;两组毒副反应:静脉炎(0vs66.67%,P<0.0001);恶心呕吐(21.74%vs90.48%,P<0.001);贫血(17.39%vs38.1%,P<0.05);QLQ-C30量表显示:在对照组中,恶心呕吐和食欲减退两个条目上,化疗后得分显著高于化疗前(P<0.01),在角色功能、疲乏、便秘和总体生活质量得分上化疗前后的差异也具有统计学意义(P<0.05);在时辰组中,化疗后病人情感和认知功能得分显著高于化疗前,总体生活质量得分较化疗前高;QLQ-LC13量表显示:病人的主要症状是呼吸困难、咳嗽和胸痛,经过2个周期的时辰化疗后均得到明显改善。结论:对于非小细胞肺癌病人,与常规给药模式相比,NP方案时辰给药具有更好的疗效、更低的毒副反应和化疗期间�展开更多
Health related quality of life(HRQOL) is increasingly recognized as an important clinical parameter and research endpoint in patients with hepatocellular carcinoma(HCC). HRQOL in HCC patients is multifaceted and affec...Health related quality of life(HRQOL) is increasingly recognized as an important clinical parameter and research endpoint in patients with hepatocellular carcinoma(HCC). HRQOL in HCC patients is multifaceted and affected by medical factor which encompasses HCC and its complications, oncological and palliative treatment for HCC, underlying liver disease, as well as the psychological, social or spiritual reaction to the disease. Many patients presented late with advanced disease and limited survival, plagued with multiple symptoms, rendering QOL a very important aspect in their general well being. Various instruments have been developed and validated to measure and report HRQOL in HCC patients, these included general HRQOL instruments, e.g., Short form(SF)-36, SF-12, Euro Qo L-5D, World Health Organization Quality of Life Assessment 100(WHOQOL-100), World Health Organization Quality of Life Assessment abbreviated version; general cancer HRQOL instruments, e.g., the European Organisation for Research and Treatment of Cancer(EORTC) QLQ-C30, Functional Assessment of Cancer Therapy(FACT)-General, Spitzer Quality of Life Index; and liver-cancer specific HRQOL instruments, e.g., EORTC QLQ-HCC18, FACT-Hepatobiliary(FACT-Hep), FACT-Hep Symptom Index, Trial Outcome Index. Important utilization of HRQOL in HCC patients included description of symptomatology and HRQOL of patients, treatment endpoint in clinical trial, prognostication of survival, benchmarking of palliative care service and health care valuation. In this review, difficulties regarding the use of HRQOL data in research and clinical practice, including choosing a suitable instrument, problems of missing data, data interpretation, analysis and presentation are examined. Potential solutions are also discussed.展开更多
文摘目的探讨康复期锻炼对乳腺癌患者生命质量的影响。方法采用横断面研究方法,整群抽样上海癌症康复俱乐部1 956名女性乳腺癌康复期患者进行问卷调查,调查问卷采用欧洲癌症研究与治疗组织生命质量量表(quality of life questionnaire-core 30,EORTC QLQ-C30)和乳腺癌生存质量量表(quality of life questionnaire-breast cancer module 23,QLQ-BR23)。结果 QLQ-BR23的信度和效度分别为0.898和0.904,EORTC QLQ-C30的信度和效度分别为0.988和0.989;对于QLQ-BR23量表,康复锻炼、锻炼次数和生命质量均无统计学意义。但是参与康复锻炼和锻炼次数≥5次/周患者的功能症状总得分高于未参加康复锻炼和康复锻炼<5次/周患者。对于EORTC QLQ-C30量表,通过调整社会人口学等因素,参加康复锻炼患者的躯体功能及总体健康状况得分均显著高于不参加体育锻炼患者(P<0.05,PAdjusted<0.05);康复锻炼≥5次/周患者的5个功能维度及总体健康状况得分均高于康复锻炼<5次/周患者,但只有躯体功能差异有统计学意义(P<0.05,PAdjusted<0.05)。结论参加康复锻炼的乳腺癌患者总体生命质量高于未参加锻炼者,康复锻炼对提高乳腺癌患者的生命质量有积极影响。
基金Supported by the Natural Science Foundation of Hubei Province(No.2013 CFB138)Hubei Province Health and Family Planning Scientific Research Project(No.WJ2015Q009)
文摘Objective To explore quality of life(QOL) and its influencing factors in patients with lung cancer.Methods A QOL questionnaire(European Organization for Research and Treatment of Cancer [EORTC] Quality of Life Questionnaire-Core 30 [QLQ-C30] Chinese version) was used with 138 patients with lung cancer participating in the study. A statistical description of the general characteristics of the patients with lung cancer was performed. The patients' QLQ-C30 scores were compared with the reference value for each dimension. To analyze the influence of QOL in different genders, age groups, and cancer stages, ttests and rank sum tests were used to compare the differences in QOL using a 5% significance level. Results The QLQ-C30 function scores in PF(physical functioning), EF(emotional functioning), SF(social functioning), and GH(global functioning), and symptom scales in NV(nausea and vomiting), DY(dyspnea), SL(insomnia), and FI(financial difficulties) were significantly different(P < 0.05) in comparison to the reference values. Female patients were worse than males(P < 0.05) in EF, NV, and DI(diarrhea). The later the stage of lung cancer, the worse the quality of life became; the functional scales in RF(role functioning), EF, CF, SF, and GH, and symptom scales in PA(pain), AP(appetite), and SL differences were statistically significant(P < 0.05). Conclusion This study aids understanding of the status of the quality of life of Chinese patients with cancer and might be useful for clinical work, theory research, and health policymakers.
基金supported by the National Natural Science Foundation of China [No.81273061]
文摘Objective The primary aim of the study was to compare two nutritional status evaluation tools： the Patient-Generated Subjective Global Assessment（PG-SGA） and Nutritional Risk Screening（NRS-2002）. Using the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30（EORTC QLQ-C30）, the second aim was to provide constructive advice regarding the quality of life of patients with malignancy. Methods This study enrolled 312 oncology patients and assessed their nutritional status and quality of life using the PG-SGA, NRS-2002, and EORTC QLQ-C30. Results The data indicate that 6% of the cancer patients were well nourished. The SGA-A had a higher sensitivity（93.73%） but a poorer specificity（2.30%） than the NRS-2002（69.30% and 25.00%, respectively） after comparison with albumin. There was a low negative correlation and a high similarity between the PG-SGA and NRS-2002 for evaluating nutritional status, and there was a significant difference in the median PG-SGA scores for each of the SGA classifications（P 〈 0.001）. The SGA-C group showed the highest PG-SGA scores and lowest body mass index. The majority of the target population received 2 points for each item in our 11-item questionnaire from the EORTC QLQ-C30. Conclusion The data indicate that the PG-SGA is more useful and suitable for evaluating nutritional status than the NRS-2002. Additionally, early nutrition monitoring can prevent malnutrition and improve the quality of life of cancer patients.
文摘目的:观察在非小细胞肺癌病人中,与常规化疗模式相比,时辰化疗在疗效、毒副反应和生活质量上是否具有优越性。方法:自2004年4月至2006年2月将NP方案以时辰给药方式治疗23例非小细胞肺癌患者为时辰组,给药方法如下:NVB12.5mg/m2/d,自15:00至03:00,峰值在21:00,d1-d4;PDD20mg/m2/d,自10:00至22:00,峰值在16:00,d1-d4;同期常规化疗21例作为对照组,对照组常规外周静脉输液,NVB25mg/m2,d1,d8;PDD25mg/m2,d3-d5;两组均为21天为1周期,每个病人至少接受2个周期化疗。采用欧洲生命质量协作组癌症核心量表(quality of life questionnaire:core30,EORTCQLQ-C30)第三版和肺癌补充问卷QLQ-LC13对患者进行自我问卷调查,所有患者于化疗前1天,2周期化疗结束后1周进行2次评估。两个量表各项原始得分经线性公式转换成0-100,功能量表和整体生活质量量表得分越高提示生活质量越好,而症状量表及单项条目得分越高提示症状越明显,生活质量越差。结果:与对照组相比,时辰组病人的中位TTP提高了1.3个月(6.2月:4.9月,P<0.05),一年生存率提高了13.25%(60.87%vs47.62%,P<0.05),而中位生存期时辰组为13.8月,对照组为11.9月,时辰组有提高的趋势,但无统计学差异;两组毒副反应:静脉炎(0vs66.67%,P<0.0001);恶心呕吐(21.74%vs90.48%,P<0.001);贫血(17.39%vs38.1%,P<0.05);QLQ-C30量表显示:在对照组中,恶心呕吐和食欲减退两个条目上,化疗后得分显著高于化疗前(P<0.01),在角色功能、疲乏、便秘和总体生活质量得分上化疗前后的差异也具有统计学意义(P<0.05);在时辰组中,化疗后病人情感和认知功能得分显著高于化疗前,总体生活质量得分较化疗前高;QLQ-LC13量表显示:病人的主要症状是呼吸困难、咳嗽和胸痛,经过2个周期的时辰化疗后均得到明显改善。结论:对于非小细胞肺癌病人,与常规给药模式相比,NP方案时辰给药具有更好的疗效、更低的毒副反应和化疗期间�
文摘Health related quality of life(HRQOL) is increasingly recognized as an important clinical parameter and research endpoint in patients with hepatocellular carcinoma(HCC). HRQOL in HCC patients is multifaceted and affected by medical factor which encompasses HCC and its complications, oncological and palliative treatment for HCC, underlying liver disease, as well as the psychological, social or spiritual reaction to the disease. Many patients presented late with advanced disease and limited survival, plagued with multiple symptoms, rendering QOL a very important aspect in their general well being. Various instruments have been developed and validated to measure and report HRQOL in HCC patients, these included general HRQOL instruments, e.g., Short form(SF)-36, SF-12, Euro Qo L-5D, World Health Organization Quality of Life Assessment 100(WHOQOL-100), World Health Organization Quality of Life Assessment abbreviated version; general cancer HRQOL instruments, e.g., the European Organisation for Research and Treatment of Cancer(EORTC) QLQ-C30, Functional Assessment of Cancer Therapy(FACT)-General, Spitzer Quality of Life Index; and liver-cancer specific HRQOL instruments, e.g., EORTC QLQ-HCC18, FACT-Hepatobiliary(FACT-Hep), FACT-Hep Symptom Index, Trial Outcome Index. Important utilization of HRQOL in HCC patients included description of symptomatology and HRQOL of patients, treatment endpoint in clinical trial, prognostication of survival, benchmarking of palliative care service and health care valuation. In this review, difficulties regarding the use of HRQOL data in research and clinical practice, including choosing a suitable instrument, problems of missing data, data interpretation, analysis and presentation are examined. Potential solutions are also discussed.
